Literature DB >> 9808849

Determinants of chronic venous disease after acute deep venous thrombosis.

M H Meissner1, M T Caps, B K Zierler, N Polissar, R O Bergelin, R A Manzo, D E Strandness.   

Abstract

PURPOSE: The purpose of this investigation was to evaluate the relationship between the presenting features of an acute deep venous thrombosis (DVT), the subsequent natural history of the thrombus, and the ultimate outcome as defined according to the Society for Vascular Surgery and the North American Chapter of the International Society for Cardiovascular Surgery reporting standards in venous disease.
METHODS: Patients with an acute DVT were followed with serial clinical and ultrasound examinations. Thrombus extent within 7 venous segments was scored retrospectively according to the reporting standards (scores ranged from 0 to 3), and segmental reflux was scored as present (1) or not present (0). The initial and final thrombus scores, the rates of recanalization and rethrombosis, and the total reflux scores were then calculated from these grading scales and related to ultimate chronic venous disease (CVD) classification.
RESULTS: Sixty-eight patients with an acute DVT in 73 limbs were followed for 18 to 110 months (mean, 55 +/- 26 months). At the completion of the follow-up period, 20 extremities (27%) were asymptomatic (class 0), 13 (18%) had pain or prominent superficial veins (class 1), 25 (34%) had manifested edema (class 3), 13 (18%) had developed hyperpigmentation (class 4), and 2 (3%) had developed ulceration (class 5). In a univariate analysis, CVD classification was correlated with the reflux score (P =.003) but not with the initial or final thrombus score or with the rate of recanalization or rethrombosis. In a multivariate model of features documented at presentation, only the tibial thrombosis score was a significant predictor of CVD classification (R2 =.06). Outcome was better predicted (R2 =.29) with a model that included variables defined during follow-up the final reflux score, the final popliteal score, and the rate of recanalization.
CONCLUSION: The ability to predict the severity of CVD after an acute DVT is currently limited, although the natural history appears more important than the presenting features of the event. The extent of reflux, the presence of persistent popliteal obstruction, and the rate of recanalization are related to ultimate CVD classification, but other determinants remain to be identified.

Entities:  

Mesh:

Year:  1998        PMID: 9808849     DOI: 10.1016/s0741-5214(98)70057-6

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  17 in total

Review 1.  The post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.

Authors:  Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

2.  Effectiveness of catheter directed thrombolysis and stent implantation on iliofemoral vein thrombosis caused by iliac vein compression.

Authors:  Zhi-Bing Ming; Wen-Dong Li; Rui-Fan Yuan; Xiao-Qiang Li; Wen-Bin Ding
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

3.  Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome.

Authors:  Konstantinos T Delis; Haraldur Bjarnason; Paul W Wennberg; Thom W Rooke; Peter Gloviczki
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

4.  Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.

Authors:  Vikram Sood; Cathy Luke; Erin Miller; Mayo Mitsuya; Gilbert R Upchurch; Thomas W Wakefield; Dan D Myers; Peter K Henke
Journal:  Ann Vasc Surg       Date:  2010-02       Impact factor: 1.466

5.  Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial.

Authors:  Ido Weinberg; Suresh Vedantham; Amber Salter; Gail Hadley; Noor Al-Hammadi; Clive Kearon; Jim A Julian; Mahmood K Razavi; Heather L Gornik; Samuel Z Goldhaber; Anthony J Comerota; Andrei L Kindzelski; Robert M Schainfeld; John F Angle; Sanjay Misra; Jonathan A Schor; Darren Hurst; Michael R Jaff
Journal:  Vasc Med       Date:  2019-07-27       Impact factor: 3.239

6.  Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.

Authors:  S A Siefert; C Chabasse; S Mukhopadhyay; M H Hoofnagle; D K Strickland; R Sarkar; T M Antalis
Journal:  J Thromb Haemost       Date:  2014-09-30       Impact factor: 5.824

7.  Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.

Authors:  Adriana Laser; Megan Elfline; Cathy Luke; Dallas Slack; Anuj Shah; Vikram Sood; Barry Deatrick; Brendan McEvoy; Carson Ostra; Anthony Comerota; Steven Kunkel; Cory Hogaboam; Peter K Henke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-12-05       Impact factor: 8.311

8.  Percutaneous options for acute deep vein thrombosis.

Authors:  Suresh Vedantham; Clay Padginton
Journal:  Semin Intervent Radiol       Date:  2005-09       Impact factor: 1.513

9.  Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life.

Authors:  Konstantinos T Delis; Dimitris Bountouroglou; Averil O Mansfield
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

10.  Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.

Authors:  Julia Humphries; James A Gossage; Bijan Modarai; Kevin G Burnand; Thomas H Sisson; Colin Murdoch; Alberto Smith
Journal:  J Vasc Surg       Date:  2009-08-22       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.